BDR Pharmaceuticals move on Remdesivir clone irks Gilead

The Indian company had submitted its application for manufacturing the Covid-19 drug to the Drug Controller General of India (DCGI) last week.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36zdcE0
via IFTTT